Inspiratory Muscle Training for Breast Cancer Survivors with Obesity
(IMOCS Trial)
Trial Summary
What is the purpose of this trial?
The investigators propose a randomized controlled trial to determine the effectiveness of inspiratory muscle training in improving exercise tolerance among stage 0-III obese breast cancer survivors.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications, but it does allow participants who are on adjuvant endocrine therapy to join.
What data supports the effectiveness of this treatment for breast cancer survivors with obesity?
Is inspiratory muscle training safe for humans?
How is inspiratory muscle training different from other treatments for breast cancer survivors with obesity?
Inspiratory muscle training (IMT) is unique because it specifically targets the muscles used for breathing, helping to reduce breathlessness and improve physical performance, which can be particularly beneficial for breast cancer survivors with obesity. Unlike other treatments that may focus on weight loss or general fitness, IMT directly enhances respiratory muscle strength, making it a practical and minimally intrusive option.12678
Research Team
Dharini M Bhammar, PhD
Principal Investigator
Ohio State University
Eligibility Criteria
This trial is for sedentary obese breast cancer survivors with a BMI of 30-50, who finished treatment for Stage 0-III cancer within the past 6 months to 5 years. Participants should have some exercise intolerance but can't join if they smoke, are pregnant/nursing, or have heart disease, severe joint issues, recent infections treated with antibiotics or steroids, or any psychiatric conditions that affect study compliance.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Inspiratory Muscle Training (IMT) or SHAM
Participants undergo 4 weeks of either IMT or SHAM training, 3 times per week, with specific intensity levels using a pressure threshold device
Exercise Training
Participants engage in 12 weeks of aerobic exercise training including cycling, walking, and elliptical, starting in week 5, 3 times per week, up to 50 minutes per session at moderate intensity
Follow-up
Participants are monitored for changes in dyspnea, fatigue, exercise capacity, and inspiratory muscle strength and endurance
Treatment Details
Interventions
- Exercise training
- Inspiratory muscle training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Lead Sponsor